Via Overnight Mail and Email Elan Drug Delivery, Inc. King of Prussia, PA 19406MAP Pharmaceuticals, Inc. • March 12th, 2009 • Pharmaceutical preparations • New York
Company FiledMarch 12th, 2009 Industry JurisdictionReference is made to that certain Services Agreement, dated as of February 3, 2005, by and between Elan Drug Delivery, Inc. (“EDDI”) and MAP Pharmaceuticals, Inc. (“MAP”), as amended by that certain First Amendment thereto, dated December 18, 2008, by and between EDDI and MAP and, with respect to which amendment AstraZeneca AB is a party to the extent set forth in Section 7 thereof (such agreement, as amended, the “Services Agreement”).
FIRST AMENDMENT TO SERVICES AGREEMENTServices Agreement • March 12th, 2009 • MAP Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMarch 12th, 2009 Company Industry JurisdictionThis FIRST AMENDMENT (“First Amendment”) is made and entered into as of the date upon which this First Amendment is fully executed by both Parties.
THIRD AMENDMENT TO LICENSE AGREEMENTLicense Agreement • March 12th, 2009 • MAP Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMarch 12th, 2009 Company Industry JurisdictionThis THIRD AMENDMENT (“Third Amendment”) is made and entered into as of the date upon which this Third Amendment is fully executed by both Parties (the “Third Amendment Effective Date”).
March 2, 2009Services Agreement • March 12th, 2009 • MAP Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMarch 12th, 2009 Company Industry JurisdictionReference is made to that certain Services Agreement (such agreement, as amended, the “Services Agreement”), dated 3rd February 2005, by and between Elan Drug Delivery, Inc. (“EDDI”) and MAP Pharmaceuticals, Inc. (“MAP”), as amended by that certain First Amendment thereto (such amendment, the “First Amendment”), dated 18th December 2008, by and between EDDI and MAP and, with respect to which amendment, AstraZeneca AB is a party to the extent set forth in Section 7 thereof, and as further amended by that Second Amendment thereto, dated 17 February 2009, by and between EDDI, MAP, and AstraZeneca AB.